Metherell Louise A, Naville Danielle, Halaby George, Begeot Martine, Huebner Angela, Nürnberg Gudrun, Nürnberg Peter, Green Jane, Tomlinson Jeremy W, Krone Nils P, Lin Lin, Racine Michael, Berney Dan M, Achermann John C, Arlt Wiebke, Clark Adrian J L
Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine, London EC1M 6BQ, United Kingdom.
J Clin Endocrinol Metab. 2009 Oct;94(10):3865-71. doi: 10.1210/jc.2009-0467. Epub 2009 Sep 22.
Familial glucocorticoid deficiency (FGD) is an autosomal recessive disorder resulting from resistance to the action of ACTH on the adrenal cortex. Affected individuals are deficient in cortisol and, if untreated, are likely to succumb to hypoglycemia and/or overwhelming infection. Mutations of the ACTH receptor (MC2R) and the melanocortin 2 receptor accessory protein (MRAP), FGD types 1 and 2 respectively, account for approximately 45% of cases.
A locus on chromosome 8 has previously been linked to the disease in three families, but no underlying gene defect has to date been identified.
The study design comprised single-nucleotide polymorphism genotyping and mutation detection.
The study was conducted at secondary and tertiary referral centers.
Eighty probands from families referred for investigation of the genetic cause of FGD participated in the study.
There were no interventions.
Analysis by single-nucleotide polymorphism array of the genotype of one individual with FGD previously linked to chromosome 8 revealed a large region of homozygosity encompassing the steroidogenic acute regulatory protein gene, STAR. We identified homozygous STAR mutations in this patient and his affected siblings. Screening of our total FGD patient cohort revealed homozygous STAR mutations in a further nine individuals from four other families.
Mutations in STAR usually cause lipoid congenital adrenal hyperplasia, a disorder characterized by both gonadal and adrenal steroid deficiency. Our results demonstrate that certain mutations in STAR (R192C and the previously reported R188C) can present with a phenotype indistinguishable from that seen in FGD.
家族性糖皮质激素缺乏症(FGD)是一种常染色体隐性疾病,由促肾上腺皮质激素(ACTH)对肾上腺皮质作用的抵抗引起。受影响的个体缺乏皮质醇,若不治疗,可能死于低血糖和/或严重感染。ACTH受体(MC2R)和黑皮质素2受体辅助蛋白(MRAP)的突变分别导致FGD 1型和2型,约占病例的45%。
8号染色体上的一个位点先前已在三个家族中与该疾病相关联,但迄今为止尚未确定潜在的基因缺陷。
研究设计包括单核苷酸多态性基因分型和突变检测。
研究在二级和三级转诊中心进行。
80名因FGD遗传病因接受调查的家族先证者参与了研究。
无干预措施。
对一名先前与8号染色体相关的FGD个体的基因型进行单核苷酸多态性阵列分析,发现一个包含类固醇生成急性调节蛋白基因(STAR)的大片纯合区域。我们在该患者及其受影响的兄弟姐妹中发现了纯合的STAR突变。对我们的FGD患者总队列进行筛查,发现另外四个家族的另外九名个体中存在纯合的STAR突变。
STAR突变通常导致类脂质性先天性肾上腺增生,这是一种以性腺和肾上腺类固醇缺乏为特征的疾病。我们的结果表明,STAR中的某些突变(R192C和先前报道的R188C)可表现出与FGD难以区分的表型。